Find Approved Gastroenterology Drugs in Clinical Development in IRELAND

Lead Product(s): Linaclotide

Therapeutic Area: Gastroenterology

Highest Development Status: Approved Product Type: Small molecule

Partner/Sponsor/Collaborator: Teva Pharmaceuticals

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement January 23, 2020

Details:

Pursuant to the terms of the settlement, Ironwood and Allergan will grant Teva a license to market its 145 mcg and 290 mcg generic version of LINZESS in U.S.